This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Catabasis Pharmaceuticals, Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Allison Wensley
Introduction
Allison Wensley is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of metabolic disease treatment through her innovative research and development. Her work focuses on the conjugation of fatty acids with statins and FXR agonists, which has the potential to improve therapeutic outcomes for patients.
Latest Patents
Wensley holds a patent for "Fatty acid conjugates of statin and FXR agonists; compositions and method of uses." This invention relates to fatty acid statin conjugates and fatty acid FXR agonist conjugates. The patent includes compositions comprising an effective amount of these conjugates and methods for treating or preventing metabolic diseases through their administration. She has 1 patent to her name.
Career Highlights
Allison Wensley is currently associated with Catabasis Pharmaceuticals, Inc., where she continues to advance her research in metabolic diseases. Her work at the company has been instrumental in developing new therapeutic strategies that leverage her innovative approaches.
Collaborations
Wensley collaborates with notable colleagues, including Jill C Milne and Michael R Jirousek. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in the pharmaceutical industry.
Conclusion
Allison Wensley's contributions to the field of metabolic disease treatment through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for new therapeutic options that can significantly impact patient care.